Which strategy is “best” after myocardial infarction? the beta-blocker strategy plus implantable cardioverter defibrillator trial: rationale and study design11This work was sponsored by Guidant Italia, S.r.l., Milan, Italy. Data coordination by INNOVEX s.r.l., Milan, Italy. For a complete list of steering committee members and participating centers, see Appendix
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Which strategy is “best” after myocardial infarction? the beta-blocker strategy plus implantable cardioverter defibrillator trial: rationale and study design11This work was sponsored by Guidant Italia, S.r.l., Milan, Italy. Data coordination by INNOVEX s.r.l., Milan, Italy. For a complete list of steering committee members and participating centers, see Appendix